Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live
Salary Range:CHF93,800.00 - CHF174,200.00 Job Description SummaryLocation: Basel, Switzerland #onsite Role Purpose: We are seeking a highly motivated Senior Expert Analytical Scientist with experience in Oligonucleotides analytics to join our Analytical Research & Development (ARD) team.
Visium combines strategy, frontier AI, and deep regulated-industry expertise to build and deploy AI-native systems that reinvent how businesses operate - unlocking the value of AI at scale. Were not a strategy firm that ships slide
Role At Visium, youll have the opportunity to take on an entrepreneurial role, contributing to the organization’s growth and finding innovative ways to create meaningful impact for clients. Your mission will involve advising C-Level executives on
About us SERAC Biosciences AG is looking for a Principal Scientist/ (Associate) Director, Medicinal Chemistry. Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics
About us Ridgeline Discovery , a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe. In recent years, Ridgeline has assembled an international team
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Viking (NYSE: VIK) is a global leader in experiential travel with a fleet of more than 100 ships, exploring 21 rivers, five oceans and all seven continents. Designed for curious travelers with interests in science, history,